2025
Approach to the Postmarket Evaluation of Consumer Wearable Technologies
Pundi K, Bhavnani S, Seninger C, Zuckerman B, Paulsen J, Aguel F, Din N, Viggiano B, Yoo R, Dalal N, Go A, Granger C, Krumholz H, Lacar K, Li R, Lin S, Mahaffey K, Mahoney M, McCall D, Hills M, Harrington R, Hernandez-Boussard T, Saha A, Shah N, Turakhia M. Approach to the Postmarket Evaluation of Consumer Wearable Technologies. JAMA Cardiology 2025, 10 PMID: 40928810, DOI: 10.1001/jamacardio.2025.3006.Peer-Reviewed Original ResearchWearable technologyConsumer wearablesConsumer wearable technologyPostmarketing evaluationReal-world dataHealth care delivery systemPatient-centered innovationCare delivery systemHealth monitoringHealth care systemHealth care resourcesAuthorization processCross-platform dataWearablePatient harmCare systemGuideline-directed treatmentCare resourcesDigital healthMedical careData qualityData completenessPostmarketing researchHealthClinical questions
2003
Cost-Effectiveness of Risk Factors
Heidenreich P, Krumholz H. Cost-Effectiveness of Risk Factors. 2003, 259-272. DOI: 10.1007/978-1-4615-6484-3_13.Peer-Reviewed Original Research
2000
Cost-Effectiveness of Risk Factors
Krumholz H, Goldman L. Cost-Effectiveness of Risk Factors. 2000, 237-250. DOI: 10.1007/978-1-4757-9310-9_13.Peer-Reviewed Original Research
1999
Cost-Effectiveness Analysis and the Treatment of Acute Coronary Syndromes
Krumholz H. Cost-Effectiveness Analysis and the Treatment of Acute Coronary Syndromes. Contemporary Cardiology 1999, 601-610. DOI: 10.1007/978-1-59259-731-4_25.Peer-Reviewed Original ResearchAcute coronary syndromeCoronary heart diseaseHealth care resourcesCost-effectiveness analysisHealth care systemHealth care expendituresCoronary syndromeCardiac eventsPharmacologic interventionsHeart diseaseEfficacious therapyCardiovascular diseaseCare resourcesNew interventionsCare expendituresCare systemHealth benefitsInterventionCare organizationsDiseaseTreatmentStandard practicePatientsHospitalSyndrome
1993
Cost-effectiveness of a smoking cessation program after myocardial infarction
Krumholz H, Cohen B, Tsevat J, Pasternak R, Weinstein M. Cost-effectiveness of a smoking cessation program after myocardial infarction. Journal Of The American College Of Cardiology 1993, 22: 1697-1702. PMID: 8227841, DOI: 10.1016/0735-1097(93)90598-u.Peer-Reviewed Original ResearchConceptsSmoking cessation programAcute myocardial infarctionNurse-managed smoking cessation programCessation programsMyocardial infarctionYears of lifeBeta-adrenergic antagonist therapyLife expectancyOne-way sensitivity analysesTwo-way sensitivity analysesCost-effective interventionHealth care resourcesAntagonist therapySmoking ratesInfarctionCare resourcesSmokersInterventionProgram costsYearsExpectancyTherapyLife
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply